Breast (Edinburgh, Scotland)
Impact of the interruption of tamoxifen for pregnancy on the recurrence and survival outcomes among young women with breast cancer.
Chihwan David Cha, Somin Jeon, Jihyun Keum, Shin Jeong Pak, Boyoung Park, Min Sung Chung
Published: 202510.1016/j.breast.2025.104675
Abstract
BACKGROUND: Young survivors of breast cancer often consider pregnancy after completing or interrupting endocrine therapy. However, concerns remain regarding the safety of tamoxifen interruption for pregnancy and its impact on survival outcomes. We ai…
Preview only. Read the full abstract at the source